Pancreatic Cancer Research

ResearcherFudan UniversityActive in the last 2 years

Jie Fan

Matched on ORCID iD 0000-0003-3842-2391; OpenAlex author ID A5100659633. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2013: 2 papers · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 9

  1. A Novel Deep Learning-based Pathomics Score for Prognostic Stratification in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002463↗
  2. Label-Free Histology and Evaluation of Human Pancreatic Cancer with Coherent Nonlinear Optical Microscopy. Co-author DOI 10.1021/acs.analchem.1c03861↗
  3. A Notch-Dependent Inflammatory Feedback Circuit between Macrophages and Cancer Cells Regulates Pancreatic Cancer Metastasis. First author DOI 10.1158/0008-5472.can-20-0256↗
  4. The roles of ID-1 in human pancreatic ductal adenocarcinoma and the therapeutic effects of 2-methoxyestradiol. Co-author DOI 10.1093/carcin/bgy035↗
  5. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.humpath.2016.05.002↗
  6. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Co-author DOI 10.1038/onc.2012.598↗
  7. The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases. First author DOI 10.1038/srep05911↗
  8. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting… Co-author DOI 10.1016/j.molonc.2012.10.011↗
  9. MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cells. Co-author DOI 10.1053/j.gastro.2013.07.048↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhen Chen · 5 shared papers, 2013–2021 · strength 0.28
  2. Deliang Fu · 3 shared papers, 2016–2021 · strength 0.27
  3. Peng Wang · 4 shared papers, 2013–2021 · strength 0.24
  4. Zhiqiang Meng · 4 shared papers, 2013–2021 · strength 0.24
  5. Lie Yao · 2 shared papers, 2018–2021 · strength 0.21
  6. Lianyu Chen · 3 shared papers, 2013–2021 · strength 0.21
  7. Wenbin Liu · 1 shared paper, 2025 · strength 0.20
  8. Yun Bian · 1 shared paper, 2025 · strength 0.20
  9. Jieyu Yu · 1 shared paper, 2025 · strength 0.20
  10. Jianping Lu · 1 shared paper, 2025 · strength 0.20
  11. Chengwei Shao · 1 shared paper, 2025 · strength 0.20
  12. Jing Li · 1 shared paper, 2025 · strength 0.20
  13. Li Wang · 1 shared paper, 2025 · strength 0.20
  14. Xinyue Zhang · 1 shared paper, 2025 · strength 0.20
  15. Chenyue Zhang · 1 shared paper, 2021 · strength 0.13
  16. Yawen Geng · 1 shared paper, 2021 · strength 0.13
  17. Chao Qu · 1 shared paper, 2021 · strength 0.13
  18. Ling Mei Qian · 1 shared paper, 2021 · strength 0.13
  19. Minbiao Ji · 1 shared paper, 2021 · strength 0.12
  20. Lili Zhang · 1 shared paper, 2021 · strength 0.12
  21. Zhongyi Guo · 1 shared paper, 2018 · strength 0.09
  22. Quanjun Lin · 1 shared paper, 2018 · strength 0.09
  23. Luming Liu · 2 shared papers, 2013–2014 · strength 0.08
  24. Juan Zhang · 2 shared papers, 2013 · strength 0.07
  25. Liping Zhuang · 2 shared papers, 2013 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.